2026-04-13T04:57:29Zhttps://recercat.cat/oai/request

oai:recercat.cat:10459.1/695952024-12-05T22:48:45Zcom_2072_3622col_2072_479130

00925njm 22002777a 4500 dc de Hollanda, Ana author Lecube Torelló, Albert author Rubio, Miguel Ángel author Sánchez Peña, Enric author Vilarrasa, Núria author Gregorio Oliva, José author Fernández-Soto, María Luisa author Salas-Salvadó, Jordi author Ballesteros-Pomar, María D. author Ciudin, Andreea author Torres, Ferran author Vidal, Concepción author Morales, María José author Valdés, Sergio author Pellitero, Silvia author Miñambres, Inka author Masmiquel, Lluís author Goday, Albert author Suarez, Lorena author Flores, Lilliam author Bueno Díez, Marta author Caixàs, Assumpta author Bretón, Irene author Cámara, Rosa author Olbeyra, Romina author Penso, Rona author de la Cruz, María José author Simó-Servat, Andreu author Pereyra-García, Francisca María author López-Mezquita, Elena Teresa author Gils, Anna author Fidilio, Enzamaria author Bandrés, Orosia author Martínez, Ángel author Abuín, Jose author Marques-Pamies, Montserrat author Tuneu, Laura author Arteaga, Magdalena author Castañer, Olga author Goñi, Fernando author Arrizabalaga, Cristina author Botana, Manuel Antonio author Calañas, Alfonso author 2020-10-02T08:28:57Z 2020-10-02T08:28:57Z 2020 Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after bariatric surgery and to evaluate the “time-within-remission range” as a variable of metabolic control. A descriptive cohort study was done using a computerised multicentre and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects with a follow-up of 4.5 ± 2.5 years were included. Type of surgery, diabetes remission, recurrence of diabetes, “time-within-remission range” and key predictors of diabetes outcomes were assessed. All patients (70% women, 51.4 ± 9.2 years old, body mass index (BMI) 46.3 ± 6.9 kg/m2 ) underwent primary bariatric procedures. “Time-within-remission range” were 83.3% (33.3–91.6) after gastric bypass, 68.7% (7.1–87.5) after sleeve gastrectomy and 90% (83.3–92.8) after malabsorptive techniques (p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly negatively correlated with the “time-within-remission range”. The association of bariatric techniques with “time-within-remission range”, using gastric bypass as a reference, were: odds ratio (OR) 3.70 (2.34–5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40–0.75), p < 0.001 for sleeve gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric surgery. The “time-within-remission range” unveils a superiority of gastric bypass compared to sleeve gastrectomy This study was supported by the Spanish Society of Endocrinology and Nutrition (SEEN). The RICIBA and RICIBA-DM are property of the Spanish Society of Endocrinology and Nutrition (SEEN). J.S.S. gratefully acknowledges the financial support by ICREA under the ICREA Academia programme. http://hdl.handle.net/10459.1/69595 Bariatric surgery Time-within-remission range Type 2 diabetes Metabolic control New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”